SCHEMBL16476451

SCHEMBL16476451

Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(CCOCCBr)c2cc1C

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.71
KMT2A Q03164 6/20 0.71
KDM4E B2RXH2 5/20 0.71
USP2 O75604 4/20 0.71
MAPT P10636 4/20 0.71
HTT P42858 3/20 0.71
TDP1 Q9NUW8 2/20 0.71
RXFP1 Q9HBX9 2/20 0.71
IDO1 P14902 1/20 0.71
HAT1 O14929 4/20 0.56
RBBP7 Q16576 4/20 0.56
KAT7 O95251 1/20 0.56
EP300 Q09472 1/20 0.56
CREBBP Q92793 1/20 0.56
RECQL P46063 3/20 0.54
CASP7 P55210 3/20 0.54
ALDH1A1 P00352 3/20 0.54
CASP1 P29466 2/20 0.54
BRCA1 P38398 2/20 0.54
HSD17B10 Q99714 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29959870 1.00 MEN1 (0.71) MEN1KMT2AKDM4EUSP2MAPT
SCHEMBL14335564 0.89 MEN1 (0.74) MEN1KMT2AKDM4EUSP2MAPT
SCHEMBL15705631 0.88 MEN1 (0.70) MEN1KMT2AKDM4EUSP2MAPT
SCHEMBL19415773 0.87 MEN1 (0.66) MEN1KMT2AKDM4EUSP2MAPT
Hydrochloric Acid SCHEMBL15665822 0.87 MEN1 (0.69) MEN1KMT2AKDM4EUSP2MAPT
SCHEMBL14335748 0.86 MEN1 (0.77) MEN1KMT2AKDM4EUSP2MAPT
SCHEMBL29959592 0.86 MEN1 (0.77) MEN1KMT2AKDM4EUSP2MAPT
SCHEMBL16476441 0.85 MEN1 (0.66) MEN1KMT2AKDM4EUSP2MAPT
SCHEMBL864786 0.84 MEN1 (0.71) MEN1KMT2AKDM4EUSP2MAPT
Bromide SCHEMBL17254515 0.84 MEN1 (0.65) MEN1KMT2AKDM4EUSP2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3586632-B1 10H-BENZO[G]PTERIDINE-2,4-DIONE DERIVATIVES, METHOD FOR PRODUCING SAME AND USE OF SAME TRIOPTOTEC GMBH (DE) 2022-09-28 EP disclosed
EP-2723743-B1 10H-BENZO[G]PTERIDINE-2,4-DIONE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF TRIOPTOTEC GMBH (DE) 2019-08-14 EP disclosed
US-9185913-B2 10H-benzo[g]pteridine-2,4-dione derivatives, method for the production thereof, and use thereof TRIOPTOTEC GMBH (DE) 2015-11-17 US disclosed
US-9185913-B2 10H-benzo[g]pteridine-2,4-dione derivatives, method for the production thereof, and use thereof TRIOPTOTEC GMBH (DE) 2015-11-17 US disclosed
US-20140200220-A1 10H-BENZO[G]PTERIDINE-2,4-DIONE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF TRIOPTOTEC GMBH (DE) 2014-07-17 US disclosed
US-20140200220-A1 10H-BENZO[G]PTERIDINE-2,4-DIONE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF TRIOPTOTEC GMBH (DE) 2014-07-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140200220-A1 10H-BENZO[G]PTERIDINE-2,4-DIONE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF DHPS, DOHH, DPYD MEN1 2099/4885KMT2A 1148/4885KDM4E 495/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.